|
1000
|
Abstract/Summary
|
-
<jats:title>Abstract</jats:title>
<jats:sec>
<jats:title>Background</jats:title>
<jats:p>Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating diagnosis. A poor outcome is known to be highly dependent on the initial neurological status. Our goal was to identify other parameters that favor the risk of complications and poor outcome in patients with aSAH and initially favorable neurologic status.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Methods</jats:title>
<jats:p>Consecutive aSAH cases treated at our hospital between 01/2003 and 06/2016 with the initial World Federation of Neurosurgical Societies grades I–III were included. Data on demographic characteristics, previous medical history, initial aSAH severity, and functional outcome after aSAH were collected. The study endpoints were the occurrence of cerebral infarcts, in-hospital mortality, and unfavorable outcome at 6 months after aSAH (modified Rankin scale > 3).</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Results</jats:title>
<jats:p>In the final cohort (<jats:italic>n</jats:italic>= 582), the rate of cerebral infarction, in-hospital mortality, and unfavorable outcome was 35.1%, 8.1%, and 17.6% respectively. The risk of cerebral infarction was independently related to the presence of acute hydrocephalus (adjusted odds ratio [aOR]=2.33, <jats:italic>p</jats:italic><0.0001), aneurysm clipping (aOR=1.78, <jats:italic>p</jats:italic>=0.003), and use of calcium channel blockers concomitant to nimodipine (aOR=2.63, <jats:italic>p</jats:italic>=0.002). Patients’ age (>55 years, aOR=4.24, <jats:italic>p</jats:italic><0.0001), acute hydrocephalus (aOR=2.43, <jats:italic>p</jats:italic>=0.036), and clipping (aOR=2.86,<jats:italic> p</jats:italic>=0.001) predicted in-hospital mortality. Baseline characteristics associated with unfavorable outcome at 6 months were age (aOR=2.77, <jats:italic>p</jats:italic>=<0.0001), Fisher grades III–IV (aOR=2.81, <jats:italic>p</jats:italic>=0.016), acute hydrocephalus (aOR=2.22, <jats:italic>p</jats:italic>=0.012), clipping (aOR=3.98, p<0.0001), admission C-reactive protein>1mg/dL (aOR=1.76, <jats:italic>p</jats:italic>=0.035), and treatment intervals (aOR=0.64 per-5-year-intervals, <jats:italic>p</jats:italic>=0.006).</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Conclusions</jats:title>
<jats:p>Although cerebral infarction is a common complication in aSAH individuals with favorable initial clinical condition, >80% of these patients show favorable long-term outcome. The knowledge of outcome-relevant baseline characteristics might help to reduce the burden of further complications and poor outcome in aSAH patients who tolerated the initial bleeding event well.</jats:p>
</jats:sec>
|
